Cargando…
NAD/NAMPT and mTOR Pathways in Melanoma: Drivers of Drug Resistance and Prospective Therapeutic Targets
Malignant melanoma represents the most fatal skin cancer due to its aggressive behavior and high metastatic potential. The introduction of BRAF/MEK inhibitors and immune-checkpoint inhibitors (ICIs) in the clinic has dramatically improved patient survival over the last decade. However, many patients...
Autores principales: | Indini, Alice, Fiorilla, Irene, Ponzone, Luca, Calautti, Enzo, Audrito, Valentina |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9456568/ https://www.ncbi.nlm.nih.gov/pubmed/36077374 http://dx.doi.org/10.3390/ijms23179985 |
Ejemplares similares
-
ROCK ‘n TOR: An Outlook on Keratinocyte Stem Cell Expansion in Regenerative Medicine via Protein Kinase Inhibition
por: Centonze, Giorgia, et al.
Publicado: (2022) -
The dual face of NAMPT: Intracellular/extracellular protein and diagnostic/therapeutic target in cancer
por: Audrito, Valentina
Publicado: (2020) -
Metabolic Interplay between the Immune System and Melanoma Cells: Therapeutic Implications
por: Indini, Alice, et al.
Publicado: (2021) -
NAMPT and NAPRT: Two Metabolic Enzymes With Key Roles in Inflammation
por: Audrito, Valentina, et al.
Publicado: (2020) -
Potential Therapeutic Effects of NAMPT-Mediated NAD Biosynthesis in Depression In Vivo
por: Wang, Jue, et al.
Publicado: (2022)